Deep-Learning-Based Detection and Segmentation
Deep-Learning-Based Detection and Segmentation
Brain Metastases
t
Funding: This work was supported in part by the National Natural Science Foundation of China (No.
ip
61802234, 61876101, 61971271), Natural Science Foundation of Shandong Province (No.
cr
ZR2019QF007), China Postdoctoral Project (No. 2017M612339), Key Technologies R & D Program of
us
Shandong Province (2017CXCG1209), and the Taishan Scholars Program (No. tsqn20161070).
an
Disclosures of Conflicts of Interest: All the authors declare no relevant relationship with any funding
Authorship Jie Xue1#, Bao Wang2#, Yang Ming3, Xuejun Liu4, Zekun Jiang5, Chengwei Wang6, Xiyu Liu1,
Ligang Chen3, Jianhua Qu1, Shangchen Xu7,8, Xuqun Tang9, Ying Mao9*, Yingchao Liu7,8*, Dengwang Li5*
ed
1
School of Business, Shandong Normal University, Jinan, 250014, China
pt
2
Department of Radiology, Qilu Hospital of Shandong University, Jinan, 250012, China
ce
3
Department of Neurosurgery, The Affiliated Hospital of Southwest Medical University, Luzhou,
Ac
646000, China
4
Department of Radiology, the Affiliated Hospital of Qingdao University Medical College, Qingdao,
266003, China
5
Shandong Key Laboratory of Medical Physics and Image Processing, School of Physics and
6
Department of Neurosurgery, the Second Hospital of Shandong University, Jinan, 250033, China
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights
reserved. For permissions, please e-mail: [email protected]
N-O-D-19-758R1
7
Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong First Medical
9
Department of Neurosurgery, Huashan Hospital Affiliated to Fudan University, Shanghai, 200040,
t
China
ip
﹟These authors contributed equally to this work.
cr
us
Authorship statement
Jie Xue, Bao Wang, Ying Mao, Dengwang Li and Yingchao Liu conceived and designed the study. Jie
an
Xue performed the experiments. Bao Wang and Yingchao Liu provided data analysis. Jie Xue and Bao
Wang wrote the paper. Yang Ming, Xuejun Liu, Zekun Jiang, Chengwei Wang, Xiyu Liu, Ligang Chen,
M
Jianhua Qu, Shangchen Xu, Ying Mao, Yingchao Liu and Dengwang Li reviewed and edited the
ed
2
N-O-D-19-758R1
Abstract
preferred in detecting brain metastases (BMs) among MRI. We developed an automatic deep-
learning-based detection and segmentation method for BMs (named BMDS net) on 3D-T1-MPRAGE
t
Methods: The BMDS net is a cascaded 3D fully convolution network (FCN) to automatically detect
ip
and segment BMs. In total, 1,652 patients with 3D-T1-MPRAGE images from three hospitals (1,201,
cr
231 and 220, respectively) were retrospectively included. Manual segmentations are obtained by a
us
neuroradiologist and a radiation oncologist in a consensus reading in 3D-T1-MPRAGE images.
Sensitivity, specificity and dice ratio of the segmentation were evaluated. Specificity and sensitivity
an
measure the fractions of relevant segmented voxels. Dice ratio was used to quantitatively measure
the overlap between automatic and manual segmentation results. Paired samples t tests and
M
Results: The BMDS net can detect all BMs, providing a detection result with an accuracy of 100%.
Automatic segmentations correlated strongly with manual segmentations through 4-fold cross
pt
validation of the dataset with 1,201 patients: the sensitivity was 0.96±0.03 (range, 0.84-0.99), the
ce
specificity was 0.99±0.0002 (range, 0.99-1.00), and the dice ratio was 0.85 ± 0.08 (range, 0.62-0.95)
for total tumor volume. Similar performance on the other two datasets also demonstrate the
Ac
robustness of BMDS net in correctly detecting and segmenting BMs in various settings.
Conclusions: The BMDS net yields the accurate detection and segmentation of BMs automatically
and could assist stereotactic radiotherapy management for the diagnosis, therapy planning and
follow up.
Key words: deep learning, fully convolution network, brain metastases, stereotactic radiotherapy,
MRI
3
N-O-D-19-758R1
Key points
2. Experimental results showed a good consistency with manual delineations by human experts.
3. BMDS net can facilitate the stereotactic radiotherapy management on brain metastases.
t
ip
Importance of the Study
cr
Detection and segmentation are essential for the clinical management of brain metastases, including
us
the diagnosis, therapy planning and follow up. Nevertheless, the manual delineations are time
an
consuming and subject to operators. With the recent advances, deep learning methods have
automatic detection and segmentation of brain metastases. Our method agrees with those of
human experts, resulting in a fast differential diagnosis, tumor delineation and tumor burden
ed
assessment with less subjective bias, and the performance was validated in an external dataset,
4
N-O-D-19-758R1
Introduction
Patients with BMs show a poor outcome without efficient treatment 1. Both an accurate diagnosis
and therapeutic strategy have a strong influence on the clinical outcomes of BMs 2. Benefiting from
efficient local control, stereotactic radiotherapy (SRT) is becoming popular in the treatment of BMs
t
ip
3-5
even in cases with more than 10 lesions and is often used instead of whole-brain radiotherapy
cr
(WBRT), yielding >80%–90% durable local control.
us
Detection and segmentation are the necessary steps in the clinical management of SRT of BMs.
However, manual delineation is time consuming and often irreproducible 6. Although time taken for
an
the BMs is associated with their size, a median value of 2.8 minutes was still recorded in finishing the
manual segmentation of per lesion in our clinical practice, while a deep learning method could
M
perform the work within 25 seconds. Moreover, omitting small and even large BMs is incidentally
ed
seen during the planning of gamma knife radiosurgery in clinical practice, because of carelessness,
exhaustion and other human factors 7. Additionally, interobserver variability in target volume
pt
8,9
delineation is another important contributor to uncertainty in SRT . Therefore, there is a calling
ce
need to develop an efficient computer-aided detection and segmentation method to help radiation
oncologists identify and cover BMs, especially under the condition of multiple brain metastases 10.
Ac
Various methods have been used to detect brain tumors. Pereira et al. 11 proposed the automatic
segmentation method based on convolutional neural network for the segmentation of glioma.
Symmetrically driven FCN 12 completed segmentation of glioma using multimodal data. Havaei et al.
13
proposed a new segmentation framework for heterogeneous multimodal MRI, which allows
segmentation of data that lacks certain modalities. Hu et al. 14 extracted multi-scale features through
multi-level convolutional neural networks, and used CRF to combine spatial context information to
15
segment glioma. A priori-driven FC-CRF combined with prior knowledge of the tumor core was
5
N-O-D-19-758R1
used to segment the tumor core. Feature recombination and spatial adaptive recalibration blocks
were proposed, and the feature maps were recalibrated to improve the segmentation result of
function to the network to explicitly encourage the learning of multi-level features. Interactive
18,19
methods were also used for segmentation of glioma. However, few works studied in brain
20
metastases. Farjam et al. used a set of unevenly spaced 3D spherical shell templates to localize
t
21
ip
BMs using T1-weight MRI. Robert et al. proposed spherical tumor appearance models to match
the expected geometry of BMs. Krafft et al. 22 utilized soft independent modeling of class analogies
cr
to cluster brain metastases.
us
To our best knowledge, no study has investigated the fully automatic segmentation of BMs
an
because of the following reasons. 1) many very small BMs exist in the brain; 2) niduses show various
distributions among either individual participants or patient groups; 3) the intensities of voxels in
M
niduses would be very similar to those of the neighboring tissues if patients were administrated with
some specific targeted drugs . With the recent advances, deep learning methods have been
23
ed
regarded as a very promising approach for medical image processing, including brain tumor
24,25
segmentation . Davy et al. divided 3D MR images into 2D images and trained a convolutional
pt
24 26 27
neural network (CNN) to predict their center pixel class . Urban et al. and Zikic et al.
ce
activation function between each layer and a softmax output layer. However, brain metastases are
Ac
uneven and sometimes very small in size. For such tumors, deep learning-based segmentation
methods can be disrupted by the nontarget region, which often occupies a large fraction in
postcontrast T1-weighted MR images. Furthermore, the methods above divided the 3D MR images
24,27 26
into 2D or 3D patches to train a CNN, unavoidably missing some spatial information across
slices. These deficiencies often resulted in inaccurate segmentation results compared to experts’
6
N-O-D-19-758R1
Aimed to overcome the abovementioned challenges and compare with the state of art method,
we proposed and evaluated a cascaded 3D fully convolution network for the detection and
proposed BMDS net will provide accurate detection and segmentation of BMs and outperform the
classical FCN. In this approach, the first FCN focuses on fast location of the region of the brain
metastases, and segmentation by the second FCN is implemented on the detected region, thereby
t
ip
reducing the influence of similar or neighboring tissues to assist the precise management of BMs
with SRT.
cr
Materials and Methods
us
Study populations
an
This study was approved by the Institutional Review Board of the three hospitals, and all
M
experiments were performed in compliance with the Declaration of Helsinki. Written informed
From October 2016 to May 2019, 1,201 cases of patients with BM from the Shandong Provincial
Hospital were retrospectively collected as Dataset 1. Two hundred thirty-one cases had been
pt
retrospectively collected from the Affiliated Hospital of Qingdao University Medical College as
ce
Dataset 2, and 220 cases were collected from the Second Hospital of Shandong University as Dataset
3. The detailed distribution of all datasets and inclusion and exclusion criteria are provided in
Ac
Supplemental Content 1. The summary results of the three datasets are provided in Supplemental
Table S1.
MRI acquisitions
All the patients from the three different institutes were examined using 3.0 T MRI machines but
with different manufacturers and imaging parameters. Detailed information about the MR machines
and imaging parameters of the three hospitals are provided in Supplemental Content 2.
7
N-O-D-19-758R1
Manual Segmentation
neuroradiologist and one radiation oncologist (with 10 years and 15 years of experience,
existed. Only the whole BMs (including both enhancing area and necrotic area) were covered for
t
ip
segmentation, avoiding adjacent vessels. Lesions that were only visible in one axial slice were not
cr
considered as a lesion for segmentation. Any lesions that occupied over two axial slices would be
segmented whatever the sizes are. Time taken of manual segmentations, and the mean value of two
us
performers’ time on one lesion was considered as the time taken of this lesion.
an
BMDS Net Architecture
M
Deep learning models can learn a hierarchy of features by building high-level features from low-
level features. The FCN 28 is a special case of a convolutional network, in which the training is an end-
ed
to-end process and embodies fewer network parameters. The FCN comprises multiple convolution
and pooling layers that reduce the number of network parameters to a large extent, without
pt
incorporating any fully connected layers. The FCN can take inputs of arbitrary size and generate
ce
same-size outputs, through efficient inference and learning. It generates dense pixel outputs by
interpolating the coarse output via deconvolution layers. Recently, the 3D FCN was developed and
Ac
applied to deal with 3D imaging data 29. The proposed BMDS net employed and further extended the
3D FCNs, involving two stages—detection and segmentation. In the detection stage, we designed a
3D FCN to rapidly localize the region of brain metastases in raw 3D T1-weighted MR images, which
will propose bounding boxes for segmentation. This can be considered as coarse segmentation of
brain metastases. The FCN is devised for fast segment brain metastases from the downsampled MR
image. Specifically, for accurate detection, the original MR image is downsampled to ¼ of its original
resolution. After inference with the proposed FCN, we upsampled the coarse segmentation results
8
N-O-D-19-758R1
to the original resolution. Next, the bounding box of brain metastases is obtained by morphological
operation on this coarse segmentation. The intermediate point of the bounding box is selected as
sizes of brain metastases. In the segmentation stage, a second 3D FCN utilizes the proposed
bounding boxes to predict segmentation masks for the brain metastases. An illustration of the
framework is shown in Fig. 1. The BMDS net iteratively compares the output masks with reference
t
ip
masks. The reference masks ensure that the network learns the relationship between MR image
contexts and these reference masks. Given new MRI data, the trained BMDS net can output the
cr
location of the brain metastases and corresponding segmented masks.
us
BMDS Net Implementation Details
an
The training data for BMDS net consist of 3D T1-weighted MR images as input and manual
segmentations as the reference masks. The size of the image was 256×256×120. For preprocessing,
M
all the intensity values were first saturated into [0, 1000]. Next, we normalized intensities into the
ed
range of [0, 1] by dividing the maximum intensity value. Particularly, BMDS net does not need to
correct deviation, remove skull or register heterogeneous images on the training data, a procedure
pt
BMDS net was trained via the standard stochastic gradient descent (SGD) algorithm using a
stepped learning rate initialized at 0.002 and decayed over the training iterations at a rate of 0.1 until
Ac
the training reached 500 epochs. A momentum of 0.9 was used to make a tradeoff between the
previously observed image and newly observed image. All the network parameters were initialized by
Xavier’s 30 method.
31
BMDS net was implemented based on the widely used TensorFlow open-source framework on
an NVIDIA Tesla V100 GPU with 32 GB of memory. Our experiments were conducted by splitting the
dataset into four folds. In each round of the 4-fold cross-validation (CV-4) procedure, three data
9
N-O-D-19-758R1
folds were employed as training cases and the remaining fold was used for testing. Ten percent of
Statistical analyses were conducted using python language (V3.7, USA). Quantitative results are
displayed as mean (± standard deviation). Paired samples t tests were used in pairwise comparison
t
between BMDS net and its baseline model (i.e., one-FCN). To evaluate the performance of automatic
ip
32
segmentation, results were compared on the level of brain metastases volume. Dice ratio
cr
computed the overlap of ground truth segmentation Vg and automatic segmentation Vs:
us
2* || Vs Vg ||
diceratio
|| Vs Vg ||
(1)
an
Specificity (or the true negative rate) and sensitivity (or the true positive rate) measure the
M
fractions of relevant segmented voxels. The definitions of these metrics are given below:
TN
ed
specificity
TN FP (2)
pt
TP
sensitivity
TP FN (3)
ce
The true positive (TP) score reflects the number of tumor voxels correctly identified as tumor
Ac
voxels. The false positive (FP) score reflects the number of non-tumor voxels incorrectly identified as
tumor voxels. The true negative (TN) score reflects the number of background voxels correctly
identified as background voxels. Finally, the false negative (FN) score reflects the number of non-
Results
BMDS net required approximately 23 hours to train, whereas labeling a single input image using the
trained model required approximately 24 s (4 s for detection and 20 s for segmentation). The
10
N-O-D-19-758R1
median time taken for manual segmentation of one lesion was 2.8 minutes (interquartile range [2.1,
4.2]). For all 1,201 cases, the first, second and third quartiles of the tumor number (range from 1 to
(i.e., the detection accuracy was 100%), ensuring the identification of all target lesions without
omission. 3D visualization of the ground-truth segmentations and our detections are shown in Fig. 2.
t
ip
In clinical practice, a higher positive predictive rate (ideally, 100%) is more preferable than a
cr
higher negative predictive rate because false segmentation can be excluded during the process of
us
planning. The BMDS net can detect all BMs, providing a detection result with an accuracy of 100%.
The minimal diameter of the smallest BM was 2 mm. The BMDS net could yield both high positive
an
predictive rate and negative predictive rate. The true positive rate (i.e., sensitivity) and true negative
rate (i.e., specificity) were 0.96±0.03 (range, 0.84-0.99) and 0.99±0.0002 (range, 0.99-1.00),
M
respectively. The diagnostic performance demonstrates the ability of BMDS net to assist the
ed
Because a lethal radiation dose of gamma knife radiotherapy could be performed on the small
ce
lesions with a diameter <= 5 mm, resulting an excellent local control. Under this condition,
Ac
interobserver variability in target volume delineation could have very limited influences on the
results of these very small lesions. In addition, Response Assessment in Neuro-Oncology Brain
Metastases (RANO-BM) suggests the target lesions for evaluation be 10 mm, but they also
supplemented that a smaller target lesion could be selected if the imaging slice thickness decreased.
Recently, Neil K, et al 33 chose to lower the minimum size limit of measurable disease to 5 mm using
a imaging slice thickness less than 1.5mm, which is gradually accepted by more institutions.
Therefore, we calculated the dice ratio of lesions with a diameter over 5 mm.
11
N-O-D-19-758R1
For the Dataset 1 of 1,201 cases, the first, second and third quartiles of the mean brain metastasis
volume (MBMV) (which is per metastasis volume, range from 0.07 cm3 to 23.81 cm3) were 0.79 cm3,
volumes (TBMVs) (which is total metastases in entire brain volume, range from 0.08 cm3 to 71.44
cm3) as the union of brain metastasis volumes from manual segmentations in the 3D T1-MPRAGE
images were 1.47 cm3, 3.86 cm3, and 10.45 cm3, respectively. The dice ratios were 0.81 ± 0.08
t
(range, 0.62-0.93) and 0.88 ± 0.07 (range, 0.71-0.95) for tumors of MBMV<4.01 cm3 and MBMV≥4.01
ip
cm3, respectively. Therefore, the proposed method works well on both small (MBMV<4.01 cm3) and
cr
large tumors (MBMV≥4.01 cm3) as shown in Fig. 3 (a).
us
Segmentation performance of BMDS net on various area sizes
an
The first, second and third quartiles of the diameter to enhance the BM area (range from 6 mm to
45 mm) were 10.50 mm, 15.75 mm, and 22.50 mm, respectively. The mean diameter of the
M
enhancing BM area was 17.58 mm. The dice ratios were 0.83 ± 0.09 (range, 0.62-0.95) and 0.89 ±
ed
0.07 (range, 0.71-0.95) for the diameters ranging from 6 to 18 mm and from 18 to 45 mm,
respectively. The results verify the effectiveness of BMDS net for BMs with different diameters, as
pt
We trained the networks for Dataset 2 (231 cases) and Dataset 3 (220 cases) using the same
training settings as those for the 1,201 cases. The mean sensitivity, specificity and dice ratio (with
standard deviation) were 0.95±0.02, 0.99±0.0001, 0.84±0.07 and 0.96±0.04, 0.99±0.0001, 0.83±0.06,
respectively. As shown in Fig. 3 (b and c), the segmentations generated by our proposed method are
highly consistent with the ground-truth segmentations for all the three datasets, indicating potential
12
N-O-D-19-758R1
The FCN is a special case of convolutional networks that is widely used in medical image
processing. We compared the segmentation performance of the proposed method with the classical
three indices over 1,201 samples of the classical FCN were 0.83±0.08, 0.99±0.0004 and 0.69±0.15,
respectively, which were all lower than those of the proposed method. In addition, we also
compared our results with the classical FCN through a paired-sample t-test. Collectively, our
t
ip
proposed method showed statistically significant improvement (p<0.001) compared with the
classical FCN. The summary of the results of the classical FCN and BMDS net is shown in Fig. 3(c and
cr
d).
us
Discussion
an
We developed a cascaded 3D fully convolution network for the detection and segmentation of
BMs (named BMDS net) using whole 3D MR images that not only would improve the accuracy of
M
localizing and segmenting BMs but also would reduce the labor intensity of SRT planning and follow-
ed
up assessment. BMDS net could detect all the BMs, ensuring the identification of all target lesions
without omission. Automated segmentation correlated well with manual segmentations, and
pt
BM and high-grade gliomas (HGGs) have different strategies of treatments, while the differential
diagnosis between the two entities is not always effortless, especially in solitary BM and HGGs 34.
Because the radiological appearance of solitary intracranial metastasis and HGGs are often similar,
this will result in misdiagnosis or delayed treatment, further affecting the prognosis. In clinical
practice, multiple lesions are considered as one of the most important imaging characteristics in
separating BMs from HGGs 35, and identifying the very small BMs in the brain would improve the
confidence of neuroradiologists when diagnosing BMs. Therefore, the detection and segmentation
13
N-O-D-19-758R1
of small BMs is also important to identify solitary lesions. Our results reveal that BMDS net could
On the one hand, gamma knife radiotherapy, which is the main technology of SRT, is usually a
one-day outpatient procedure that requires fast segmentation for a rapid clinical workflow 35. On the
t
other hand, omitting small and even large BMs is incidentally seen during the planning of gamma
ip
knife radiosurgery in clinical practice because of carelessness, exhaustion and other human factors 7.
cr
To solve this clinical problem, an automatic method of detection and segmentation is urgently
us
needed. Our BMDS net has a strong potential to help radiation oncologists accelerate the workflow
without omission of lesions. An example of quick segmentation of all the multiple small BMs by
an
BMDS net is shown in Fig. 5.
M
Although the proposed method still omitted some slices of tumors, this result may not discourage
radiation oncologists because almost all the omitting slices are the begin and ending slices of BMs.
ed
The radiation oncologists could make amends in the process of planning; particularly, the beginning
and ending slices should not always be included (partial volume effect).
pt
Because assessment of the treatment response is mostly based on the change in the lesion
Ac
volume, a quick and visualized spatial distribution of all lesions would liberate the neuro-oncologists
from measuring the volumes repeatedly. Moreover, conditions of new lesions appearing or old
lesions disappearing would coexist during the follow up. Therefore, the identification of spatial
distribution and volumetric changes is crucial to assess the treatment response of each lesion and
help treatment decision making. BMDS net could display the spatial distribution and volumetric
changes of BM accurately and simplify the treatment response evaluation. An example of the
segmentations in the pretreatment and follow up of one patient is shown in Fig. 6. Regarding the
14
N-O-D-19-758R1
Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) 36, lesions with a diameter
greater than 1 cm should be considered as target lesions for treatment response assessment. Our
Vascular epidermal growth factor (VEGF) receptor inhibitor , as the first-line treatment modality
for brain metastases 37, have always caused a dilemma concerning evaluation during the follow-up
t
ip
assessment of BMs because these agents could tighten the vascular endothelial space and further
cr
decrease the permeability of the ruptured blood brain barrier, preventing contrast agent leakage
into the extravascular and extracellular space and resulting in light or no enhancement in the
us
postcontrast T1WI images of patients with BMs. Therefore, identifying all the lesions would be more
an
challenging. Remarkably, BMDS net performed well in detecting and segmenting nonenhancing BMs.
This is an important progress for the clinical management of SRT of BMs. An example of segmenting
M
nonenhancing lesions after VEGF receptor inhibitor treatment by BMDS net is shown in
There are several limitations in this study. First, only 3D T1-MPRAGE images (similar to 3D BRAVO
pt
T1WI) were included in the study. Other 3D imaging sequences are also used in clinical practice—for
different flip angle evolutions (3D T1-SPACE); the diagnostic performance of BMDS net in these
Ac
imaging sequences should be investigated in a future study. Second, in the first stage of BMDS net,
we could not afford any missing detected region of a case; thus, we chose a fixed size of the located
nidus region. Additionally, we know that an adaptive method will be more flexible. In future work,
we will explore more stable region proposal methods based on the predicted region size to alleviate
Conclusion
15
N-O-D-19-758R1
In this paper, we have proposed a cascaded 3D FCN to automatically detect and segment brain
metastases, in which the first FCN focuses on fast location and the second on segmentations.
all the BMs, ensuring the identification of all target lesions without omission, but also segment
lesions with high accuracy and robustness. The BMDS net shows great potential in help separating
BM from HGGs, simplifying treatment planning and facilitating the follow up of BMs. The deep-
t
ip
learning-based method could be a useful tool to reduce the labor intensity of clinicians in the clinical
management of BMs.
cr
Acknowledgements
us
We would like to thank American Journal Expert for English language editing.
an
M
ed
pt
ce
Ac
16
N-O-D-19-758R1
References
t
5. Pinkham MB, Whitfield GA, Brada M. New developments in intracranial stereotactic
ip
radiotherapy for metastases. Clinical Oncology. 2015;27(5):316-323.
6. Pérez‐Ramírez Ú, Arana E, Moratal D. Brain metastases detection on MR by means of three‐
cr
dimensional tumor‐appearance template matching. Journal of Magnetic Resonance Imaging.
2016;44(3):642-652.
7. Higuchi Y, Yamamoto M, Serizawa T, Aiyama H, Sato Y, Barfod BE. Modern management
us
for brain metastasis patients using stereotactic radiosurgery: literature review and the authors’
gamma knife treatment experiences. Cancer management and research. 2018;10:1889.
8. Growcott S, Dembrey T, Patel R, Eaton D, Cameron A. Inter-Observer Variability in Target
an
Volume Delineations of Benign and Metastatic Brain Tumours for Stereotactic Radiosurgery:
Results of a National Quality Assurance Programme. Clinical Oncology. 2019.
9. Chang ATY, Tan LT, Duke S, Ng W-T. Challenges for quality assurance of target volume
delineation in clinical trials. Frontiers in Oncology. 2017;7:221.
M
10. Rudie JD, Rauschecker AM, Bryan RN, Davatzikos C, Mohan S. Emerging applications of
artificial intelligence in neuro-oncology. Radiology. 2019;290(3):607-618.
11. Pereira S, Pinto A, Alves V, Silva CA. Brain tumor segmentation using convolutional neural
networks in MRI images. IEEE transactions on medical imaging. 2016;35(5):1240-1251.
ed
12. Shen H, Zhang J, Zheng W. Efficient symmetry-driven fully convolutional network for
multimodal brain tumor segmentation. Paper presented at: 2017 IEEE International
Conference on Image Processing (ICIP)2017.
13. Havaei M, Guizard N, Chapados N, Bengio Y. Hemis: Hetero-modal image segmentation.
pt
Paper presented at: International Conference on Medical Image Computing and Computer-
Assisted Intervention2016.
ce
segmentation. Paper presented at: 2017 IEEE International Conference on Image Processing
(ICIP)2017.
16. Pereira S, Pinto A, Amorim J, Ribeiro A, Alves V, Silva CA. Adaptive feature recombination
and recalibration for semantic segmentation with Fully Convolutional Networks. IEEE
transactions on medical imaging. 2019.
17. Chen S, Ding C, Liu M. Dual-force convolutional neural networks for accurate brain tumor
segmentation. Pattern Recognition. 2019;88:90-100.
18. Wang G, Li W, Zuluaga MA, et al. Interactive medical image segmentation using deep
learning with image-specific fine tuning. IEEE transactions on medical imaging.
2018;37(7):1562-1573.
19. Wang G, Zuluaga MA, Li W, et al. DeepIGeoS: a deep interactive geodesic framework for
medical image segmentation. IEEE transactions on pattern analysis and machine intelligence.
2018;41(7):1559-1572.
17
N-O-D-19-758R1
20. Farjam R, Parmar HA, Noll DC, Tsien CI, Cao Y. An approach for computer-aided detection
of brain metastases in post-Gd T1-W MRI. Magnetic resonance imaging. 2012;30(6):824-
836.
t
networks. Medical image analysis. 2017;35:18-31.
ip
25. Shen D, Wu G, Suk H-I. Deep learning in medical image analysis. Annual review of
biomedical engineering. 2017;19:221-248.
26. Urban G, Bendszus M, Hamprecht F, Kleesiek J. Multi-modal brain tumor segmentation
cr
using deep convolutional neural networks. MICCAI BraTS (Brain Tumor Segmentation)
Challenge Proceedings, winning contribution. 2014:31-35.
27. Zikic D, Ioannou Y, Brown M, Criminisi A. Segmentation of brain tumor tissues with
us
convolutional neural networks. Proceedings MICCAI-BRATS. 2014:36-39.
28. Sun W, Wang R. Fully convolutional networks for semantic segmentation of very high
resolution remotely sensed images combined with DSM. IEEE Geoscience and Remote
an
Sensing Letters. 2018;15(3):474-478.
29. Nie D, Wang L, Adeli E, Lao C, Lin W, Shen D. 3-D fully convolutional networks for
multimodal isointense infant brain image segmentation. IEEE transactions on cybernetics.
2018;49(3):1123-1136.
M
30. Glorot X, Bengio Y. Understanding the difficulty of training deep feedforward neural
networks. 2010. Paper presented at: International Conference on Artificial Intelligence and
Statistics2018.
31. Tensorflow. https://www.tensorflow.org/.
ed
32. Dice LR. Measures of the amount of ecologic association between species. Ecology.
1945;26(3):297-302.
33. Taunk NK, Oh JH, Shukla-Dave A, et al. Early posttreatment assessment of MRI perfusion
pt
biomarkers can predict long-term response of lung cancer brain metastases to stereotactic
radiosurgery. Neuro-oncology. 2017;20(4):567-575.
34. Jung BC, Arevalo‐Perez J, Lyo JK, et al. Comparison of glioblastomas and brain metastases
ce
36. Lin NU, Lee EQ, Aoyama H, et al. Response assessment criteria for brain metastases:
proposal from the RANO group. The lancet oncology. 2015;16(6):e270-e278.
37. Roca E, Pozzari M, Vermi W, et al. Outcome of EGFR-mutated adenocarcinoma NSCLC
patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors:
A pooled analysis with an additional case. Lung Cancer. 2018.
18
N-O-D-19-758R1
Figures Legends
represents the ground-truth segmentations (up), and the second row (down) represents our
t
Figure 3. Comparison between various volumes and size of the enhancing area for each slice (a);
ip
comparison among different datasets (b and c); comparison between BMDS net and the classic
cr
FCN (d). BMDS net achieved a better dice ratio among BMs with a MBMV greater than 4.01 cm3
us
and a diameter greater than 18 mm (a); a high sensitivity, specificity and dice ratio were reached using
BMDS net among the three different datasets (b); the receiver operating characteristic curve of BMDS
an
for three different datasets and the classic FCN (C); BMDS net showed higher sensitivity, specificity
Figure 4. Example of segmentation of small enhancing lesions to avoid the misdiagnosis of BMs. A
58-year-old female patients without a history of primary cancer complained of dizziness and
ed
memory deterioration. An inhomogeneous enhancing lesion was obviously seen in the right
thalamus (A). However, a very small nidus was also identified in the left cerebellum (B-C), suggesting
pt
a high possibility of the diagnosis of brain metastases. (D) Manual segmentation. The predicted
ce
segmentations (E) showed good concordance with manual labels. The specificity, sensitivity and dice
Figure 5. Example of segmentation of multiple brain metastases by BMDS net. A 67-year-old male
patient with a history of lung cancer had a chief complaint of headache. Contrast-enhanced 3D T1-
MPRAGE images showed multiple brain metastases in the brain (A). The brain metastases were
separately segmented manually using various colored labels. (C) Manual segmentation in a spatial
view. The predicted segmentations (D) showed strong concordance with the manual labels. The
specificity, sensitivity and dice ratio were 0.99, 0.93 and 0.86, respectively.
19
N-O-D-19-758R1
Figure 6. Example of tumor burden changes between pretreatment (a) and the follow up (b) of one
patient. A 49-year-old male patient with multiple BMs was treated by stereotactic radiotherapy.
performed (B and E). Posttreatment images (C and G) showed that the lesions decreased.
Additionally, a new metastatic lesion was discovered (white G). The lesions were also manually
segmented (D and H). Manual pretreatment (I) and posttreatment (K) segmentations showed strong
t
ip
concordance with the predicted pretreatment (K) and posttreatment (L) segmentations by BMDS
net. The specificity, sensitivity and dice ratio of pretreatment segmentations were 0.99, 0.97 and
cr
0.85, respectively, while those of posttreatment segmentations were 0.99, 0.97 and 0.80,
us
independently. an
M
ed
pt
ce
Ac
20
Downloaded from https://academic.oup.com/neuro-oncology/advance-article-abstract/doi/10.1093/neuonc/noz234/5684915 by University of Toronto user on 25 December 2019
t
ip
cr
us
an
N-O-D-19-758R1
Figure 1
21
M
ed
pt
ce
Ac
Downloaded from https://academic.oup.com/neuro-oncology/advance-article-abstract/doi/10.1093/neuonc/noz234/5684915 by University of Toronto user on 25 December 2019
t
ip
cr
us
an
N-O-D-19-758R1
Figure 2
22
M
ed
pt
ce
Ac
Downloaded from https://academic.oup.com/neuro-oncology/advance-article-abstract/doi/10.1093/neuonc/noz234/5684915 by University of Toronto user on 25 December 2019
t
ip
cr
us
an
N-O-D-19-758R1
Figure 3
23
M
ed
pt
ce
Ac
Downloaded from https://academic.oup.com/neuro-oncology/advance-article-abstract/doi/10.1093/neuonc/noz234/5684915 by University of Toronto user on 25 December 2019
t
ip
cr
us
an
N-O-D-19-758R1
Figure 4
24
M
ed
pt
ce
Ac
Downloaded from https://academic.oup.com/neuro-oncology/advance-article-abstract/doi/10.1093/neuonc/noz234/5684915 by University of Toronto user on 25 December 2019
t
ip
cr
us
an
N-O-D-19-758R1
Figure 5
25
M
ed
pt
ce
Ac
Downloaded from https://academic.oup.com/neuro-oncology/advance-article-abstract/doi/10.1093/neuonc/noz234/5684915 by University of Toronto user on 25 December 2019
t
ip
cr
us
an
N-O-D-19-758R1
Figure 6
26
M
ed
pt
ce
Ac